Lingling Tong

436 total citations
20 papers, 271 citations indexed

About

Lingling Tong is a scholar working on Molecular Biology, Cancer Research and Biomedical Engineering. According to data from OpenAlex, Lingling Tong has authored 20 papers receiving a total of 271 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 6 papers in Cancer Research and 5 papers in Biomedical Engineering. Recurrent topics in Lingling Tong's work include Cancer-related molecular mechanisms research (5 papers), Nanoplatforms for cancer theranostics (4 papers) and MicroRNA in disease regulation (3 papers). Lingling Tong is often cited by papers focused on Cancer-related molecular mechanisms research (5 papers), Nanoplatforms for cancer theranostics (4 papers) and MicroRNA in disease regulation (3 papers). Lingling Tong collaborates with scholars based in China, Taiwan and United States. Lingling Tong's co-authors include Ao Yu, Sun‐Lin Chung, Liudong Ren, Dongdong Liu, Tianyu Yu, Hejia Zhang, Kun Wang, Aichen Zhang, Shujie Pang and Longyun Li and has published in prestigious journals such as RSC Advances, American Journal of Science and Breast Cancer Research and Treatment.

In The Last Decade

Lingling Tong

17 papers receiving 264 citations

Peers

Lingling Tong
Xuewei Yan China
Zhuoxuan Li China
Haiyong Li China
Qingchun Li China
Huizi Wang China
Xue Guo China
Jingfang Zhao China
Xuewei Yan China
Lingling Tong
Citations per year, relative to Lingling Tong Lingling Tong (= 1×) peers Xuewei Yan

Countries citing papers authored by Lingling Tong

Since Specialization
Citations

This map shows the geographic impact of Lingling Tong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lingling Tong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lingling Tong more than expected).

Fields of papers citing papers by Lingling Tong

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lingling Tong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lingling Tong. The network helps show where Lingling Tong may publish in the future.

Co-authorship network of co-authors of Lingling Tong

This figure shows the co-authorship network connecting the top 25 collaborators of Lingling Tong. A scholar is included among the top collaborators of Lingling Tong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lingling Tong. Lingling Tong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
Wang, Ziqi, Xia Xiao, Wenyang Liu, et al.. (2024). Integrated analysis and systematic characterization of the regulatory network for human germline development. Journal of genetics and genomics. 52(2). 204–219. 1 indexed citations
4.
5.
Tong, Lingling, et al.. (2024). Prediction of high-level fear of cancer recurrence in breast cancer survivors: An integrative approach utilizing random forest algorithm and visual nomogram. European Journal of Oncology Nursing. 70. 102579–102579. 5 indexed citations
6.
7.
Tong, Lingling, Jingjing Cao, Kun Wang, Jibin Song, & Jing Mu. (2023). Lanthanide‐Doped Nanomaterials for Tumor Diagnosis and Treatment by Second Near‐Infrared Fluorescence Imaging. Advanced Optical Materials. 12(4). 14 indexed citations
8.
Zhang, Aichen, et al.. (2021). LncRNA FGD5-AS1 promotes the malignant phenotypes of ovarian cancer cells via targeting miR-142-5p. APOPTOSIS. 26(5-6). 348–360. 18 indexed citations
9.
Tong, Lingling, Wei Zhang, Jia Zhao, & Kai Li. (2020). Influence of different rates of programmed intermittent epidural administration in labor analgesia in lying-in women. 46(1). 149–153. 1 indexed citations
10.
Yu, Tianyu, et al.. (2020). <p>Upregulation of TRIAP1 by the lncRNA MFI2-AS1/miR-125a-5p Axis Promotes Thyroid Cancer Tumorigenesis</p>. OncoTargets and Therapy. Volume 13. 6967–6974. 10 indexed citations
11.
Zhang, Aichen, et al.. (2020). ZFAT and smart sensor promotes the progression of cervical cancer through mitotic pathway. Measurement. 164. 108051–108051.
12.
Tong, Lingling, et al.. (2019). CREB1 induced lncRNA HAS2-AS1 promotes epithelial ovarian cancer proliferation and invasion via the miR-466/RUNX2 axis. Biomedicine & Pharmacotherapy. 115. 108891–108891. 35 indexed citations
13.
14.
Tong, Lingling, et al.. (2019). Hydrogels with self-healing ability, excellent mechanical properties and biocompatibility prepared from oxidized gum arabic. European Polymer Journal. 117. 363–371. 41 indexed citations
15.
Ge, Xiaoguang, Bin Chen, Wei Lan, et al.. (2019). Active targeting drug-gold nanorod hybrid nanoparticles for amplifying photoacoustic signal and enhancing anticancer efficacy. RSC Advances. 9(24). 13494–13502. 8 indexed citations
16.
Sun, Xiaochun, Manhua Cui, Lingling Tong, Aichen Zhang, & Kun Wang. (2018). Upregulation of microRNA-3129 suppresses epithelial ovarian cancer through CD44. Cancer Gene Therapy. 25(11-12). 317–325. 10 indexed citations
17.
Zhang, Hejia, et al.. (2018). Synergistic combination of PEGylated selenium nanoparticles and X-ray-induced radiotherapy for enhanced anticancer effect in human lung carcinoma. Biomedicine & Pharmacotherapy. 107. 1135–1141. 25 indexed citations
18.
Tong, Lingling. (2013). The progress in diagnosis and treatment of ovarian cancer.
19.
20.
Xie, Hongwei, et al.. (2006). Related Factor Analysis of Middle School Students' Obesity in H City. Practical Preventive Medicine. 13(2). 324–325. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Xuewei Yan Breakdown of academic impact, for papers by Zhuoxuan Li Breakdown of academic impact, for papers by Haiyong Li Breakdown of academic impact, for papers by Qingchun Li Breakdown of academic impact, for papers by Huizi Wang Breakdown of academic impact, for papers by Xue Guo Breakdown of academic impact, for papers by Jingfang Zhao
Rankless by CCL
2026